These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 6128980)

  • 41. Decreased ATPase and increased sodium content of platelets in Down's syndrome. Relation to decreased serotonin content.
    McCoy EE; Segal DJ; Bayer SM; Strynadka KD
    N Engl J Med; 1974 Oct; 291(18):950-3. PubMed ID: 4278048
    [No Abstract]   [Full Text] [Related]  

  • 42. The effects of angiotensin II and genetic hypertension upon extracellular nucleotide hydrolysis by rat platelet ectoenzymes.
    Fürstenau CR; Trentin DS; Barreto-Chaves ML; Sarkis JJ
    Thromb Res; 2007; 120(6):877-84. PubMed ID: 17343900
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Activity of ecto-ATPase in different populations of mouse and rat lymphocytes.
    Hennighausen G; Lange P
    Biomed Biochim Acta; 1985; 44(7-8):1269-72. PubMed ID: 2935145
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Study of the enzymatic activity in the platelets. ATPase activity and content of ATP in the platelets of normal children].
    BERNI CANANI M; REA F; DIFRANCESCOL ; SCHETTINI F
    Boll Soc Ital Biol Sper; 1961 Oct; 37():1013-5. PubMed ID: 13868189
    [No Abstract]   [Full Text] [Related]  

  • 45. Interaction of alpha and beta receptor blocking agents with platelet release and availability reaction induced by ADP, adrenaline and collagen.
    Kubisz P; Caen J
    Pathol Biol (Paris); 1972 Dec; ():Suppl:34-40. PubMed ID: 4145190
    [No Abstract]   [Full Text] [Related]  

  • 46. Pharmacological profiles of YM-16151-1 and its optical isomers: a novel calcium entry blocking and selective beta-1 adrenoceptor blocking agent.
    Asano M; Uchida W; Shibasaki K; Terai M; Inagaki O; Takenaka T; Matsumoto Y; Fujikura T
    J Pharmacol Exp Ther; 1990 Jul; 254(1):204-11. PubMed ID: 1973196
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of different glycosaminoglycans on myosin ATPase activity in platelets.
    Volpi N; Bianchini P; Bolognani L
    Biochem Pharmacol; 1991 Mar 15-Apr 1; 41(6-7):1077-80. PubMed ID: 1826199
    [No Abstract]   [Full Text] [Related]  

  • 48. [Effect of Chinoin-103 on Na+, K+-activated adenosine triphosphatase of the rat heart].
    Szabó J; Nosztray K; Papp Z; Szegi J
    Acta Pharm Hung; 1989 Jul; 59(4):179-88. PubMed ID: 2570501
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of beta-adrenoceptor blockers on mitochondrial ATPase activity in guinea pig heart preparations.
    Almotrefi AA; Dzimiri N
    Eur J Pharmacol; 1992 May; 215(2-3):231-6. PubMed ID: 1356792
    [TBL] [Abstract][Full Text] [Related]  

  • 50. alpha 1-Adrenoceptor agonist activity of alpha 2-adrenoceptor antagonists in the pithed rat preparation.
    Paciorek PM; Shepperson NB
    Br J Pharmacol; 1983 May; 79(1):12-4. PubMed ID: 6135473
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Platelet abnormality in Wiskott-Aldrich syndrome.
    Hadden JW; Holmes-Gray B; Good RA
    N Engl J Med; 1970 Oct; 283(16):876-7. PubMed ID: 4248132
    [No Abstract]   [Full Text] [Related]  

  • 52. Actin-linked regulation of the human platelet contractile system.
    Cohen I; Kaminski E; De Vries A
    FEBS Lett; 1973 Aug; 34(2):315-7. PubMed ID: 4270615
    [No Abstract]   [Full Text] [Related]  

  • 53. [Properties of erythrocyte anion ATPase].
    Ivashchenko AT; Li T; Bushneva IA
    Vopr Med Khim; 1985; 31(1):117-21. PubMed ID: 3157265
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [The role of prostaglandins in the effect of beta-blockers on stimulated blood platelets].
    Nosál' R; Jancinová V; Petríková M
    Vnitr Lek; 1991 Mar; 37(3):261-7. PubMed ID: 1674390
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mammalian platelet adrenoceptors.
    Kerry R; Scrutton MC; Wallis RB
    Br J Pharmacol; 1984 Jan; 81(1):91-102. PubMed ID: 6322894
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Inhibition of sarcolemmal ATPase and pNPPase by CH-103.
    Nosztray K; Szabó J; Varga E; Szegi J
    Acta Physiol Hung; 1990; 75 Suppl():225-6. PubMed ID: 1973566
    [No Abstract]   [Full Text] [Related]  

  • 57. Influence of nonselective beta-adrenergic impacts on the effects of thrombocytopoietin in mice.
    Negrev N; Ganchev T
    Acta Physiol Pharmacol Bulg; 1987; 13(1):35-40. PubMed ID: 2887086
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Calcium entry blocking, beta 1-adrenoceptor blocking and hypotensive effects of YM-16151-4.
    Shibasaki K; Uchida W; Matsuda Y; Asano M
    Arch Int Pharmacodyn Ther; 1991; 313():140-50. PubMed ID: 1687772
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Antihypertensive effect of arotinolol (S-596), a new adrenergic beta blocking agent, on experimental hypertension].
    Hara Y; Nakahara H; Miyagishi A; Nakatani H
    Nihon Yakurigaku Zasshi; 1983 Aug; 82(2):103-16. PubMed ID: 6198264
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of the selective beta 1-adrenoceptor antagonist, nebivolol, on cardiovascular parameters in the pithed normotensive rat.
    Schneider J; Fruh C; Wilffert B; Peters T
    Pharmacology; 1990; 40(1):33-41. PubMed ID: 1970437
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.